EMBL's scientists have been instrumental in helping the world understand, decode, archive, and manipulate genomes at scale ...

The latest group of winning technologies has a little something for everyone—from scientists at the lab bench to those in the ...

At ASH's annual meeting, a study showed the potential for this method to inform the next treatment after patients relapse on BCMA- or GPRC5D-targeted therapy.

A team of scientists with two Department of Energy Bioenergy Research Centers have identified a gene in a poplar tree that ...

Natera, Inc. , a global leader in cell-free DNA and genetic testing, and MyOme, a leading clinical whole genome analysis and polygenic risk modeling company, today announced the launch of an ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, and MyOme, a leading clinical whole genome ...

In this interview, Wirulda Pootakham, the Director of Thailand's National Omic Centre, talks to NewsMedical about genomic ...

Researchers at the National Institutes of Health (NIH) found previously undetected cancers in 48.6% of pregnant people who ...

This study reveals distinct immune subpopulations associated with specific myeloma cell genotypes and highlights the central ...

By inferring proliferation rates from single-cell genomics, SPRINTER enhances understanding of tumor evolution and identifies ...

Synaffix B.V., a Lonza company (SIX:LONN) focused on commercializing its clinical-stage bioconjugation platform technology for the ...

A team of scientists with two Department of Energy Bioenergy Research Centers — the Center for Bioenergy Innovation, or CBI, ...